Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients

scientific article published on September 2009

Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.15.4170
P932PMC publication ID2738814
P698PubMed publication ID19725152
P5875ResearchGate publication ID26784495

P50authorTian-Fu WenQ111586918
P2093author name stringBo Li
Jin Li
Zhe-Yu Chen
Jian Yang
Yong Zeng
Ji-Chun Zhao
Jia-Yin Yang
Lu-Nan Yan
Ming-Qing Xu
Wen-Tao Wang
Yu-Kui Ma
P2860cites workGlobal cancer statistics, 2002Q27860562
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosisQ29619508
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosisQ34515064
Prognostic prediction and treatment strategy in hepatocellular carcinoma.Q34547469
Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?Q36098393
Indications for liver transplantation in hepatobiliary malignancyQ40658075
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?Q40780775
Hepatic resection versus transplantation for hepatocellular carcinomaQ43946793
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patientsQ44498208
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experienceQ44654109
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in JapanQ45258006
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survivalQ46743120
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcomeQ47240294
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.Q50951290
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinomaQ61937491
Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinomaQ72511270
Milan multicenter experience in liver transplantation for hepatocellular carcinomaQ72901682
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinomaQ73433778
Liver organ allocation for hepatocellular carcinoma: are we sure?Q73576939
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimetersQ77847343
Liver transplantation for hepatocellular carcinomaQ78347522
Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteriaQ81498523
P433issue33
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)4170-4176
P577publication date2009-09-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleIndicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients
P478volume15

Reverse relations

cites work (P2860)
Q38059620A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.
Q37619486Adult to adult right lobe living donor liver transplantation: does biological relationship matter?
Q36111140Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Q51773097Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases.
Q47566919Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
Q82978560Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma
Q57494813Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Q40603978Impact of Histological Factors of Hepatocellular Carcinoma on the Outcome of Liver Transplantation
Q37795703Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart?
Q38046482Liver transplantation and expanded Milan criteria: does it really work?
Q26750463Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
Q87010059Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience
Q34067940Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation
Q89953527Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma
Q37708048Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison
Q64943233Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.
Q37378982Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
Q38615125Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma
Q43467782Predictors of patient survival following living donor liver transplantation.
Q38243059Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria
Q60912071Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?
Q33913779Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.
Q37876384Which matters most: number of tumors, size of the largest tumor, or total tumor volume?

Search more.